Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

The role of doxorubicin in non-viral gene transfer in the lung.

Griesenbach U, Meng C, Farley R, Gardner A, Brake MA, Frankel GM, Gruenert DC, Cheng SH, Scheule RK, Alton EW.

Biomaterials. 2009 Apr;30(10):1971-7. doi: 10.1016/j.biomaterials.2008.12.037.

PMID:
19152975
2.

Gene therapy for cystic fibrosis: a clinical perspective.

Alton EW, Geddes DM.

Gene Ther. 1995 Mar;2(2):88-95. Review.

PMID:
7536619
3.

Current status of gene therapy for cystic fibrosis pulmonary disease.

Kennedy MJ.

Am J Respir Med. 2002;1(5):349-60. Review.

PMID:
14720037
4.

Gene therapy progress and prospects: cystic fibrosis.

Griesenbach U, Ferrari S, Geddes DM, Alton EW.

Gene Ther. 2002 Oct;9(20):1344-50. Review.

5.

Progress towards gene therapy for cystic fibrosis.

Tate S, Elborn S.

Expert Opin Drug Deliv. 2005 Mar;2(2):269-80. Review.

PMID:
16296753
6.

Airway epithelium directed gene therapy for cystic fibrosis.

White AF, Ponnazhagan S.

Med Chem. 2006 Sep;2(5):499-503. Review.

PMID:
17017989
7.

Non-viral vectors in cystic fibrosis gene therapy: progress and challenges.

Montier T, Delépine P, Pichon C, Férec C, Porteous DJ, Midoux P.

Trends Biotechnol. 2004 Nov;22(11):586-92. Review.

PMID:
15491803
8.

Non-viral vectors in cystic fibrosis gene therapy: recent developments and future prospects.

Pringle IA, Hyde SC, Gill DR.

Expert Opin Biol Ther. 2009 Aug;9(8):991-1003. doi: 10.1517/14712590903055029. Review.

PMID:
19545217
9.

Gene therapy for cystic fibrosis lung disease: current status and future perspectives.

Rosenecker J, Huth S, Rudolph C.

Curr Opin Mol Ther. 2006 Oct;8(5):439-45. Review.

PMID:
17078386
10.

Advances in cystic fibrosis gene therapy.

Griesenbach U, Geddes DM, Alton EW.

Curr Opin Pulm Med. 2004 Nov;10(6):542-6. Review.

PMID:
15510064
11.

Non-viral gene transfer therapy for cystic fibrosis.

Ziady AG, Davis PB, Konstan MW.

Expert Opin Biol Ther. 2003 Jun;3(3):449-58. Review.

PMID:
12783613
12.

Gene therapy for cystic fibrosis: an example for lung gene therapy.

Griesenbach U, Geddes DM, Alton EW.

Gene Ther. 2004 Oct;11 Suppl 1:S43-50. Review.

PMID:
15454956
13.

Gene therapy progress and prospects: cystic fibrosis.

Griesenbach U, Geddes DM, Alton EW.

Gene Ther. 2006 Jul;13(14):1061-7. Review.

PMID:
16819538
14.

Gene therapy for cystic fibrosis airway disease- is clinical success imminent?

Anson DS, Smith GJ, Parsons DW.

Curr Gene Ther. 2006 Apr;6(2):161-79. Review.

PMID:
16611040
15.

[Organ-, region- and cell-selective gene transfer using non-viral vectors].

Fumoto S.

Yakugaku Zasshi. 2009 Sep;129(9):1055-61. Review. Japanese.

16.

The development of gene therapy for diseases of the lung.

Gill DR, Davies LA, Pringle IA, Hyde SC.

Cell Mol Life Sci. 2004 Feb;61(3):355-68. Review.

PMID:
14770298
17.

Gene transfer to the lung: lessons learned from more than 2 decades of CF gene therapy.

Griesenbach U, Alton EW; UK Cystic Fibrosis Gene Therapy Consortium..

Adv Drug Deliv Rev. 2009 Feb 27;61(2):128-39. doi: 10.1016/j.addr.2008.09.010. Review.

PMID:
19138713
18.

Adenoviral and AAV-mediated gene transfer to the inner ear: role of serotype, promoter, and viral load on in vivo and in vitro infection efficiencies.

Luebke AE, Rova C, Von Doersten PG, Poulsen DJ.

Adv Otorhinolaryngol. 2009;66:87-98. doi: 10.1159/000218209. Review.

PMID:
19494574
19.

Airway gene therapy.

Davies JC, Alton EW.

Adv Genet. 2005;54:291-314. Review.

PMID:
16096016
20.

Gene transfer: the challenge of regulated gene expression.

Guo ZS, Li Q, Bartlett DL, Yang JY, Fang B.

Trends Mol Med. 2008 Sep;14(9):410-8. doi: 10.1016/j.molmed.2008.07.003. Review.

PMID:
18692441
Items per page

Supplemental Content

Support Center